Results 1 to 10 of about 9,915,878 (374)

Graves’ disease [PDF]

open access: yesNature Reviews Disease Primers, 2020
Graves' disease (GD) is an autoimmune disease that primarily affects the thyroid gland. It is the most common cause of hyperthyroidism and occurs at all ages but especially in women of reproductive age. Graves' hyperthyroidism is caused by autoantibodies to the thyroid-stimulating hormone receptor (TSHR) that act as agonists and induce excessive ...
Davies, Terry F.   +8 more
semanticscholar   +9 more sources

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

open access: yesBMC Endocrine Disorders, 2018
Background Radioactive iodine (I131) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis.
Erin Fanning   +2 more
doaj   +2 more sources

Microchimerism in Graves' Disease [PDF]

open access: yesJournal of Thyroid Research, 2012
Microchimerism is the presence of cells from one individual in another genetically distinct individual. Pregnancy is the main cause of natural microchimerism through transplacental bidirectional cell trafficking between mother and fetus. The consequences of pregnancy-related microchimerism are under active investigation.
Galofre, J.C. (Juan Carlos)
openaire   +7 more sources

Epidemiology, management and outcomes of Graves’ disease—real life data [PDF]

open access: yesEndocrine, 2017
PurposeTreatment options in Graves’ disease are clearly defined, but management practices and the perceptions of success are varied. The outcomes of treatment in large consecutive cohorts of Graves’ disease have not been well characterised.
Y. Hussain   +3 more
semanticscholar   +3 more sources

Graves’ Disease [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2007
Rebecca, Bahn   +2 more
semanticscholar   +5 more sources

Current and Future Treatments for Graves’ Disease and Graves’ Ophthalmopathy [PDF]

open access: bronzeHormone and Metabolic Research, 2018
The course and pathogenesis of Graves’ disease and Graves’ ophthalmopathy are interdependent, influencing each other’s therapeutic choices. Multiple factors including geographic location, access to medical services, patient and physician preferences ...
Anupam Kotwal, Marius N. Stan
openalex   +2 more sources

Thyroid function disorders [PDF]

open access: yesArhiv za farmaciju, 2022
Thyroid function disorders are the most common endocrine disorders in humans. They are frequently diagnosed, with prevalence varying between 2 and 6%, and a female to male ratio of up to 10:1.
Stojković Mirjana
doaj   +1 more source

What kind of therapeutic solutions for Graves’ disease does modern medicine propose? - a review of the literature

open access: yesJournal of Education, Health and Sport, 2023
Background: Graves' disease is responsible for 60-80% causes of hyperthyreosis. An important role in the pathogenesis is played by anti-TSHR immunoglobulins (TRAb), that stimulate TSH receptors leading to excessive hormone synthesis and release by the ...
Natalia Woś   +9 more
doaj   +1 more source

The genetics of Graves’ disease

open access: yesReviews in Endocrine & Metabolic Disorders, 2023
Graves’ disease (GD) is the commonest cause of hyperthyroidism and has a strong female preponderance. Everyday clinical practice suggests strong aggregation within families and twin studies demonstrate that genetic factors account for 60-80% of risk of ...
Lydia Grixti, L. Lane, S. Pearce
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy